pyrroles has been researched along with Bullous Dermatoses in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eldik, H; Leung, N; Ramirez, MR; Sodha, P | 1 |
Berg, BC; Chow, S; Suwattee, P; Warshaw, EM | 1 |
Eickert, A; Hunzelmann, N; König, C; Krieg, T; Scharfetter-Kochanek, K | 1 |
3 other study(ies) available for pyrroles and Bullous Dermatoses
Article | Year |
---|---|
Oral Tofacitinib Treatment of Erosive Pustular Dermatosis of the Scalp.
Topics: Administration, Oral; Aged; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Treatment Outcome | 2019 |
Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
Topics: Antineoplastic Agents; Carcinoid Tumor; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Mouth Mucosa; Mucositis; Pyrroles; Risk Assessment; Skin Diseases, Vesiculobullous; Sunitinib; Treatment Outcome | 2008 |
Linear IgA bullous dermatosis induced by atorvastatin.
Topics: Anticholesteremic Agents; Atorvastatin; Drug Eruptions; Heptanoic Acids; Humans; Immunoglobulin A; Male; Middle Aged; Pyrroles; Skin Diseases, Vesiculobullous | 2001 |